This paper reviews the preclinical and clinical data for ibrutinib when used in the treatment of CLL. Recent studies showing the benefit of combination therapy using ibrutinib, monoclonal antibodies, and chemoimmunotherapy are also discussed.
Ibrutinib: an evidence-based review of its pot... - CLL Support
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia...
Written by
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
a-r-ibrutinib-plus-rituximab-for-the-treatment-of-patients-with-chronic-lymphocytic-leukemia-cll--83
BTK C481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia
this is some great research on ibrutinib resistance by Dr. Woyach....
Treatment and ocular lymphocytic leukemia
temporarily but treatment was necessary. I didnt know then that there is ocular CLL and that it was...
Chronic lymphocytic leukemia
leukemia
I have cll for about a year my last appointment my white blood cells when from 34000 to...
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
first year of ibrutinib and does not preclude extended therapy.
Lots to read here:...
Related Posts
Chronic lymphocytic leukemia- Information on chronic lymphocytic leukemia
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)- Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
- A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
